{
    "title": "Bristol Myers, bluebird to resubmit cancer therapy filing as FDA declines review",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8315455/U-S-FDA-declines-review-Bristol-Myers-bluebird-therapy-multiple-myeloma.html",
    "date": "2020-05-13",
    "keywords": [
        "therapy",
        "cvr",
        "application",
        "bristol",
        "fda",
        "deadline",
        "joseph",
        "myeloma",
        "july",
        "drug",
        "treatment",
        "idecel",
        "march",
        "decision",
        "review",
        "patient",
        "cart",
        "value",
        "approval",
        "co",
        "wednesday",
        "end",
        "regulator",
        "information",
        "food",
        "administration",
        "manufacturing",
        "addition",
        "partner",
        "bluebird",
        "bio",
        "purchase",
        "celgene",
        "corp",
        "fdas",
        "refusal",
        "letter",
        "priority",
        "label",
        "cell",
        "lot",
        "forth",
        "health",
        "officer",
        "samit",
        "hirawat",
        "conference",
        "call",
        "place",
        "data",
        "class",
        "engineering",
        "tumor",
        "contingent",
        "payment",
        "share",
        "week",
        "lisocel",
        "part",
        "payout",
        "dec",
        "potential",
        "president",
        "hematology",
        "unit",
        "trading",
        "timeline",
        "time",
        "analyst",
        "reporting",
        "sibi",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}